TetraLogic Pharmaceuticals Corporation
TLOG
TLOG was delisted on the 3rd of November, 2016.
31 hedge funds and large institutions have $30.6M invested in TetraLogic Pharmaceuticals Corporation in 2014 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 6 closing their positions.
117% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 6
24% more funds holding
Funds holding: 25 → 31 (+6)
16% more capital invested
Capital invested by funds: $26.4M → $30.6M (+$4.16M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
33% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$445K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$388K |
| 3 |
CCA
Catalyst Capital Advisors
Huntington,
New York
|
+$313K |
| 4 |
TAM
Tocqueville Asset Management
New York
|
+$159K |
| 5 |
NIP
Nicholas Investment Partners
Rancho Santa Fe,
California
|
+$85.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PRCM
Pine River Capital Management
Minnetonka,
Minnesota
|
-$873K |
| 2 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$808K |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$66.8K |
| 4 |
Morgan Stanley
New York
|
-$66.4K |
| 5 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
-$51.3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BCM
26
Bridgeway Capital Management
Houston,
Texas
| $48K | +$45K | +10,050 | New |
|
|
GT
27
Glenmede Trust
Philadelphia,
Pennsylvania
| $18K | – | – | – |
|
|
BWA
28
Burt Wealth Advisors
North Bethesda,
Maryland
| $13K | +$11.7K | +2,625 | New |
|
|
TRCT
29
Tower Research Capital (TRC)
New York
| $8K | +$1.68K | +375 | +26% |
|
30
Wells Fargo
San Francisco,
California
| $5K | +$4.47K | +1,000 | New |
|
|
BIM
31
BlackRock Investment Management
Wilmington,
Delaware
| $3K | – | – | – |
|
|
PRCM
32
Pine River Capital Management
Minnetonka,
Minnesota
| – | -$873K | -209,900 | Closed |
|
|
SFM
33
Sphera Funds Management
Tel Aviv,
Israel
| – | -$808K | -194,200 | Closed |
|
|
OC
34
Oppenheimer & Co
New York
| – | -$48K | -11,500 | Closed |
|
|
TH
35
Timber Hill
Greenwich,
Connecticut
| – | -$46K | -10,985 | Closed |
|
36
Citigroup
New York
| – | -$4K | -854 | Closed |
|
37
BNP Paribas Financial Markets
Paris,
France
| – | -$890 | -214 | Closed |
|
TLOG Hedge Fund Activity: Q4 2014 in Review
31 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in TetraLogic Pharmaceuticals Corporation (TLOG) for Q4 2014, worth a combined $30.6M — up 16% from $26.4M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new TLOG positions and 6 closed out — a net gain of 7 holders — while 4 added to existing stakes and 6 trimmed.
The largest buyer was Point72 Asset Management, opening a new position worth an estimated $445K. The largest seller was Pine River Capital Management, exiting entirely with an estimated $873K sold.
- 31 institutional investors held TetraLogic Pharmaceuticals Corporation (TLOG) as of Q4 2014, up from 25 in Q3 2014.
- Funds reported $30.6M of TetraLogic Pharmaceuticals Corporation stock for Q4 2014, up 16% quarter-over-quarter.
- 13 funds opened new TetraLogic Pharmaceuticals Corporation positions in Q4 2014 and 6 closed out, a net change of +7 holders.
- The largest TetraLogic Pharmaceuticals Corporation buyer in Q4 2014 was Point72 Asset Management, an estimated $445K added.
- The largest TetraLogic Pharmaceuticals Corporation seller in Q4 2014 was Pine River Capital Management, an estimated $873K sold.
Based on aggregated 13F filings for Q4 2014.